research translation initiatives

Research Translation Initiatives (RTI) is a biotechnology venture studio and development company focused on bridging the gap between academic discovery and clinical application. The company identifies high-potential early-stage therapeutic assets from academic institutions and applies a rigorous translational framework to advance them toward IND-enabling studies. RTI's business model involves forming lean, asset-centric subsidiaries to develop specific programs across diverse therapeutic areas, including oncology and rare diseases. By providing centralized drug discovery expertise and strategic management, RTI aims to de-risk novel modalities and accelerate the delivery of breakthrough therapies to patients.